CTT Pharmaceutical Holdings, Inc. (CTTH)
USD 0.07
(88.78%)
USD 0.07
(88.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -21.09 Thousand | -138.83 Thousand | -600.25 Thousand | -186.22 Thousand | -390.44 Thousand | -299.65 Thousand |
| Net Income | -42.21 Thousand | -53.44 Thousand | -133.07 Thousand | -586.34 Thousand | -585.86 Thousand | -1.72 Million |
| Depreciation & Amortization | 6398.00 | 6398.00 | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 14.72 Thousand | -91.78 Thousand | -560.19 Thousand | 222.91 Thousand | -13.98 Thousand | 112.89 Thousand |
| Other non-cash items | 12.75 Thousand | 93.93 Thousand | 653.2 Thousand | -34.98 Thousand | 44.57 Thousand | 1.17 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 13 Thousand | 44.83 Thousand | 500.37 Thousand | - | 50.00 | 941.57 Thousand |
| Debt repayment | -10 Thousand | - | -168.08 Thousand | - | - | -941.57 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -71.4 Thousand | - | - | - | - | - |
| Common Stock Issuance | 84.4 Thousand | 44.83 Thousand | - | - | 50.00 | - |
| Other Financing Activities | - | - | 332.28 Thousand | - | - | - |
| Accounts receivables | 44.00 | 5558.00 | -13.00 | -29.00 | -4204.00 | 48.63 Thousand |
| Accounts payables | 3791.00 | -86.69 Thousand | -560.17 Thousand | 212.21 Thousand | 169.03 Thousand | 89.26 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 14.67 Thousand | -97.34 Thousand | - | 10.72 Thousand | -178.81 Thousand | -25 Thousand |
| Cash at beginning of period | 8096.00 | 102.09 Thousand | 202.15 Thousand | 388.78 Thousand | 780.09 Thousand | 136.53 Thousand |
| Cash at end of period | 1.00 | 8096.00 | 102.09 Thousand | 202.15 Thousand | 388.78 Thousand | 780.09 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -8095.00 | -94 Thousand | -100.05 Thousand | -186.62 Thousand | -391.31 Thousand | 643.55 Thousand |
| Free Cash Flow | -21.09 Thousand | -138.83 Thousand | -600.25 Thousand | -186.22 Thousand | -390.44 Thousand | -299.65 Thousand |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6427.00 | -42.21 Thousand | -872.00 | -9826.00 | -25.09 Thousand | -53.44 Thousand |
| Depreciation & Amortization | 6398.00 | 6398.00 | - | - | - | 6398.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 10.88 Thousand | 14.72 Thousand | - | 3812.00 | 23.00 | -91.78 Thousand |
| Other non-cash items | -204.00 | 12.75 Thousand | 1.00 | 999.00 | 12 Thousand | 93.93 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 3.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2120.00 | 13 Thousand | 880.00 | - | 10 Thousand | 44.83 Thousand |
| Debt repayment | -10.88 Thousand | -10 Thousand | -880.00 | - | -10 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -71.4 Thousand | -71.4 Thousand | - | - | - | - |
| Common Stock Issuance | 84.4 Thousand | 84.4 Thousand | - | - | - | 44.83 Thousand |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | 44.00 | - | - | - | 5558.00 |
| Accounts payables | - | 3791.00 | - | - | - | -86.69 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 7045.00 | 14.67 Thousand | - | 3812.00 | 23.00 | -97.34 Thousand |
| Cash at beginning of period | 22.00 | 8096.00 | 14.00 | 5029.00 | 8096.00 | 102.09 Thousand |
| Cash at end of period | -1.00 | 1.00 | 22.00 | 14.00 | 5029.00 | 8096.00 |
| Capital Expenditure | 3.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -23.00 | -8095.00 | 8.00 | -5015.00 | -3067.00 | -94 Thousand |
| Free Cash Flow | -2140.00 | -21.09 Thousand | -871.00 | -5015.00 | -13.06 Thousand | -138.83 Thousand |
NP5
EAX
MEE
DGIK
BNZIW
KABRAEXTRU